gliclazide and endothelin-1

gliclazide has been researched along with endothelin-1 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, L; Renier, G1
Edwards, TM; Verwey, LJ1

Other Studies

2 other study(ies) available for gliclazide and endothelin-1

ArticleYear
The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells.
    Atherosclerosis, 2009, Volume: 204, Issue:1

    Topics: Administration, Oral; Antioxidants; Aorta; Apoptosis; Caspase 3; Caspase 9; Caspase Inhibitors; Cells, Cultured; Cysteine Proteinase Inhibitors; Endothelial Cells; Endothelin-1; Gliclazide; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Matrix Metalloproteinase 9; NF-kappa B; Oxidative Stress; Proto-Oncogene Proteins c-akt; Scavenger Receptors, Class E

2009
Gap junctions and memory: an investigation using a single trial discrimination avoidance task for the neonate chick.
    Neurobiology of learning and memory, 2010, Volume: 93, Issue:2

    Topics: Animals; Astrocytes; Avoidance Learning; Central Nervous System Agents; Chickens; Dose-Response Relationship, Drug; Endothelin-1; Gap Junctions; Glycyrrhetinic Acid; Memory; Memory, Short-Term; Neuropsychological Tests; Random Allocation; Time Factors; Tolbutamide

2010